FDA — authorised 30 April 2014
- Application: NDA022308
- Marketing authorisation holder: BAUSCH AND LOMB
- Indication: Manufacturing (CMC)
- Status: approved
🇺🇸 Besivance in United States
FDA authorised Besivance on 30 April 2014
Marketing authorisation
Besivance in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Besivance approved in United States?
Yes. FDA authorised it on 30 April 2014.
Who is the marketing authorisation holder for Besivance in United States?
BAUSCH AND LOMB holds the US marketing authorisation.